CD36 and metabolic dysfunction-associated steatotic liver disease: A well-known scavenger receptor, CD36 has been reported as a potential diagnostic and treatment target in NAFLD progression for hepatic inflammation via mediating uptake of FFA and some modified low-density lipoprotein, especially for oxidized low-density lipoprotein (oxLDL)13,14.